An international research project led by QUT has made a major step forward on the potential of the Australian plant, N. benthamiana, to grow therapeutic proteins and vaccines cheaply and quickly. The research, titled “A multi-omic Nicotiana benthamiana resource for fundamental research and biotechnology” and published in Nature Plants, has determined the complete genome sequence of this plant, which has been used in the production of least three COVID-19 vaccines and three COVID-19 testing kits.
Click here for original story, Genetic blueprint for vaccine and therapeutics production in plants
Source: Phys.org